M3DICINE Pty
About M3DICINE Pty
M3DICINE Pty is an Australian healthcare AI company dedicated to democratizing healthcare through the development of connected, elegant medical devices powered by intelligent, intuitive software. Their flagship product, the Stethee Pro, is an AI-enabled, wireless digital stethoscope system designed for the advanced detection and analysis of cardiac and respiratory vital signs. This system has achieved regulatory clearances from the US FDA, European authorities (CE), and the Australian Therapeutic Goods Administration (TGA), underscoring its clinical validation and readiness for broad medical application.
For healthcare professionals, the Stethee Pro offers a transformative tool that captures and measures critical parameters such as systole and diastole durations, heart rate, and respiratory rate in approximately 20 seconds, a significant improvement over traditional methods. This capability provides an unprecedented depth of insight into cardiac and respiratory function, enabling clinicians to establish comprehensive baselines, track disease progression, and correlate patient data over time. Positioned for the evolving landscape of remote, personalized, and precision medicine, M3DICINE’s technology facilitates enhanced telemedicine capabilities by allowing for real-time monitoring and analysis of vital signs, thereby empowering professionals to deliver high-quality care efficiently. The company is also expanding its portfolio to include other AI-enabled devices for capturing a broader range of vital signs, with continuous AI platform updates designed to enhance diagnostic and management capabilities across various diseases.
Focus Areas
Business Intelligence
| Key Investors | Fyrfly Venture Partners, Pond Capital, Government of Queensland, Advance Queensland |
| Partnerships | UCSF Health, Mayo Clinic, MIT, Cleveland Clinic, Royal Brompton Hospital (advisors/partners); Korea Telecom (distribution); Cargill Korea (distribution for Stethee Vet); Queensland University of Technology, Kuraby Cardiac Investigation Centre (CRC-P partners); Sinskey Labs at MIT, University of Malaysia, Texas A&M, Australia Zoo Hospital, University of Sydney, Texas Heart (research agreements) |
| Acquisitions | None |
| Technology | Aida AI engine, M3DICINE Central cloud-based data platform, Bluetooth connectivity to iOS/Android apps |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, M3DICINE's Stethee Pro offers a revolutionary approach to auscultation and vital sign capture. It significantly reduces the time required to obtain cardiac and respiratory vital signs to just 20 seconds, saving valuable clinical time. The device provides objective, quantitative data, moving beyond the subjectivity of traditional stethoscopes, which can enhance diagnostic confidence and lead to more personalized treatment plans. The ability to visualize heart and lung sounds through phonocardiograph (PCG) and spectrogram views, along with patented displays like AIDA Cycle and AIDA Energy, offers an unprecedented level of detailed insight into cardiac function and respiratory patterns. Its wireless design and integration with mobile and web applications facilitate remote patient monitoring and telemedicine consultations, expanding the reach of care. Furthermore, the system allows for easy recording, secure sharing of data with colleagues, and direct import of patient vital sign reports into Electronic Health Records (EHRs), streamlining workflow and improving comprehensive patient records. The continuous updates to the AI platform mean the device becomes more intelligent over time, potentially aiding in the screening, diagnosis, and management of a wider range of diseases.
The Stethee Pro system is designed for seamless integration into existing clinical workflows. It features a HIPAA-compliant Central Web Portal and mobile applications (iOS and Android) that securely connect with the Stethee Pro device. Data captured can be easily generated into patient vital sign reports and imported directly into Electronic Health Records (EHRs), ensuring comprehensive and accessible patient records. The platform also allows for remote access and sharing of vital signs with authorized providers and colleagues, fostering collaboration.
What the Web Says
M3DICINE Pty is an Australian medical device and AI data platform company known for its 'Stethee Pro,' an AI-enabled, wireless digital stethoscope. The Stethee Pro is designed to capture and analyze cardiac and respiratory vital signs, aiming to improve remote care and telemedicine. The company is also developing other AI-enabled devices for capturing vital signs from various parts of the body.
Overall: MixedStrengths
- The Stethee Pro is the world's first AI-enabled, wireless digital stethoscope.
- It can measure respiratory rate and cardiac vital signs in just 20 seconds.
- The device supports remote care and telemedicine by allowing data capture anywhere, anytime.
- It can be used by both clinicians and patients at home.
- M3DICINE is developing a range of AI-enabled devices beyond the stethoscope.
- The company aims to provide actionable machine learning based insights and health intelligence to clinicians.
Limitations
- Specific product or employer reviews for M3DICINE Pty on platforms like G2, Glassdoor, Capterra, or Reddit were not found in the search results.
- The search results did not provide detailed feedback on company culture, salaries, benefits, or work-life balance directly related to M3DICINE Pty.
- There is no information available regarding customer service experiences or potential product issues from user reviews.
Based on reviews from: business.gov.au, Indeed.com, Capterra, G2
Last updated: 2026-07-22
Videos
News, demos, and interviews about M3DICINE Pty.
Videos load interactively. If none appear, search YouTube for M3DICINE Pty →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]